Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can move your Mounjaro injection day, but the gap between doses matters. Tirzepatide is a once-weekly medicine, and the Mounjaro SmPC is clear: if you need to shift the day you inject, the new day should be at least four days after your previous dose. Do it once, then stick to the new day each week going forward. These are prescription-only medicines that require clinical oversight, so any planned change to your schedule is worth running past your prescriber first — particularly if you are mid-titration or managing side effects.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before moving your injection day, count the days since your last dose. The Mounjaro SmPC (the definitive clinical reference for tirzepatide) sets a clear floor: the new dose must be at least four days after the previous one. Not 72 hours. Four days. So if you normally inject on a Monday and want to move to Friday, you cannot simply take Friday's dose on the same week; you would need to wait until at least Thursday of that same week at the earliest, then shift to Friday the following week. The NHS medicines page for tirzepatide outlines this same principle under guidance for missed or delayed doses, and it applies equally to deliberate day changes.
Getting the count right matters because tirzepatide's half-life means stacking doses too close together raises the risk of intensified side effects, nausea and vomiting in particular. Taking a dose too early is not something that can be undone. Check the date, check the gap, then proceed.
If your last dose was more than 12 days ago, you are approaching missed-dose territory. If it was more than 14 days, the standard advice is to restart as though it were a new dose, which may mean going back to 2.5mg depending on how long the gap has been. That is a decision for your prescriber, not one to make independently.
Once you have confirmed the gap is at least four days, you inject on the new day. That single dose acts as the bridge between your old schedule and the new one. There is nothing special about the injection itself; the process is identical to your usual weekly dose. Rotate your injection site as normal (abdomen, thigh or upper arm) and use a fresh needle.
A practical note from the routine side: if the new day means you are injecting at a different time of day than usual, that is fine. Mounjaro can be taken at any time of day, with or without food. Some people find it useful to pair their injection with a fixed weekly habit (the same gym bag packed, the same bin day, a standing calendar reminder) to make the new day stick. The pen needs to come out of the fridge 30 minutes before use; building that into the routine from the start prevents a cold-pen injection, which can be uncomfortable.
Once this bridging dose is done, the new day is your day. Write it down, update any reminder you use, and treat it as settled.
The benefit of once-weekly dosing is that consistency keeps tirzepatide's effect steady in your system. The SURMOUNT-1 trial (published in the New England Journal of Medicine and covering over 2,500 adults with obesity) used a fixed weekly schedule throughout its 72-week duration, and that regularity underpinned the average weight reductions of around 20% seen at the highest dose. Irregular intervals chip away at that consistency. One deliberate, well-managed day change is fine. Drifting by a day here and there, week after week, is a different matter.
If your reason for moving the day is an upcoming event, travel, or a clash with a regular commitment, that context is useful information for your prescriber, and our page on whether you can move your Mounjaro injection day covers the key considerations worth thinking through before you do. You can find full guidance on timing considerations on our page on choosing the best injection day for Mounjaro.
For a fuller look at what changing your Mounjaro injection day involves week by week, including scenarios like holiday travel, that page walks through the practicalities in more detail.
Moving a day once, with the gap in range, is generally straightforward. There are situations where checking in first is the right call. If you are currently increasing your dose and the day change coincides with an upcoming titration step, coordinate the two changes together with your prescriber rather than making them independently. Similarly, if you have been experiencing significant gastrointestinal side effects at your current dose, adjusting timing is a conversation worth having, it is possible your prescriber has suggestions about time of day that could help.
Any gap that crept over 14 days (whether through illness, supply issues or a missed delivery) should be discussed before your next injection. The Mounjaro injection guide covers the standard process in full, and the broader picture of how Mounjaro works as a treatment may be helpful context if you are newer to tirzepatide.
Mounjaro is a prescription-only medicine, and a prescriber reviews your treatment at every repeat at nume. If the day change raises any questions about your dose or schedule, our team is available seven days a week. If cost or continuity of supply is part of what is driving a scheduling question, our Mounjaro pricing page sets out what is included across the full treatment.
Questions about your specific circumstances are best directed to the clinical team. You can reach us via the contact page, or take a look at our FAQs for answers to the questions our prescribers hear most often.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.